- Innovation, Projects, Research

A project on diagnostics and clinical management of tuberculosis, led by the IGTP, receives Marie Skłodowska Curie Funding

The project, called "Innovation in Tuberculosis - INNOVA4TB", is promoted and coordinated by the research group Innovation in Respiratory Infections and Tuberculosis Diagnosis, led by Dr Jose Domínguez and Dr Cristina Prat.  The proposal has received more than a million euros in funding from the 2018 call for Marie Skłodowska-Curie (MSCA) actions

- Research

Understanding multimorbidity to improve its prevention

In a recent collaborative work, led by researchers from IDIBELL-ICO (ProCURE, Oncobell programs), IDIAP Jordi Gol and GCAT (Genomes of Life, IGTP), the main diseases and associations that contribute significantly to the appearance of multimorbidity are identified. The study also points out inherited genetic factors that have an influence on the appearance of multimorbidity

- Research

Pere-Joan Cardona enters the Royal European Academy of Doctors

Pere-Joan Cardona is a physician specialized in microbiology and parasitology and leader of the Experimental Tuberculosis Unit, which has been researching tuberculosis for 20 years at the Germans Trias i Pujol Research Institute (IGTP).  Cardona was sworn in as full academician of the Royal European Academy of Doctors (RAED) on Tuesday in a ceremony in the auditorium at Fomento de Trabajo Nacional in Barcelona.  Emili Gironella Masgrau made the formal proposal speech.

- Research

Non-invasive stent monitoring techniques tested

Researchers have developed a new non-invasive probe to detect the presence of metallic stents and monitor their potential structural failures in models of coronary artery disease. The new probe, which has been successfully tested on a murine model, would enable the substitution of surgical controls in patients with stents with a simple outpatient procedure. The study results from a collaboration between researchers from the Germans Trias i Pujol Research Institute (IGTP), the University of Barcelona (UB) and Universitat Politècnica de Catalunya (UPC).

- Research

New IGTP spin-off to develop gene therapy for Friedreich’s ataxia, a rare neurodegenerative disease

Biointaxis, the new spin-off company of the IGTP, was recently constituted. The company stems from research led by Dr Antoni Matilla-Dueñas together with Dr Ivelisse Sánchez of the Neurogenetics Group of the IGTP and has been created to increase translational research leading to treatments and new genomic technologies for rare neurological diseases with genetic causes.  The first project the company is undertaking is the development of a gene therapy for Friedreich's Ataxia.

- Research

Overview on recommendations on alcohol consumption for patients with liver disease

Dr Daniel Fuster of the Addiction Unit of the Internal Medicine Service at the Germans Trias i Pujol University Hospital and Research Institute (IGTP) and the Universitat Autònoma de Barcelona has co-authored a landmark review article on alcohol use in patients with chronic liver disease with Dr Jeffrey H Samet of Boston Medical Center and University School of Medicine.  The article has been published in the New England Journal of Medicine.

- Research

Proof of the importance of the Mediterranean diet for adults with diabetes type 1

Researchers at the Biomedical Research Institute of Lleida (IRBLleida), the Germans Trias i Pujol Research Institute (IGTP) and the Spanish Networked Group CIBER Diabetes and Associated Metabolic Diseases (CIBERDEM) have shown that adult patients with diabetes type 1 (DT1) have healthier eating habits and stick closer to the Mediterranean diet than non-diabetic subjects.It has been published in the European Journal of Nutrition and is the first study that tracks the adherence to the Mediterranean diet in this type of patient.A study has also evaluated the positive benefits of exercise for people with diabetes type 1.

- Research

A study in patients with heart failure points to new prognostic markers for the disease

Researchers of the Cardiovascular Disease Group and the CIBERCV Group, led by Dr Antoni Bayés Genís, have advanced the study of prognostic markers for heart failure, a progressive disease and a public health problem of the first order. They have studied monocyte (a type of white blood cell) count and distribution in a cohort of 400 outpatients with heart failure with a view to showing their predictive value. The study has been published in PLoS One.